Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10619	Companies
225665	Keywords
154242	Articles
119416	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 01/21/2025 at 07:00, 1 year 5 months ago

Biophytis et AskHelpU signent un accord de co-développement dans les maladies rares neuromusculaires en Chine
Biophy's et AskHelpU signent un accord de co-développement dans les maladies rares neuromusculaires en Chine. Analyse de l'efficacité du candidat-médicament BIO101 de Biophytis dans la SLA

Maladies Rares Biophy's SLA Co-développement AskHelpU
REGULATED PRESS RELEASE

published on 01/21/2025 at 07:00, 1 year 5 months ago

Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Biophy's and AskHelpU sign a co-development agreement for rare neuromuscular diseases in China. The agreement aims to evaluate BIO101's efficacy in ALS, potentially offering a major therapeutic solution for patients

Biophy's ALS AskHelpU Co-development Agreement Neuromuscular Diseases
BRIEF

published on 01/14/2025 at 07:05, 1 year 5 months ago

Biophytis Enters Exclusive Negotiations for BIO101 in China

Biophytis Age-related Diseases BIO101 Pharmaceutical Partnership China Licensing
BRIEF

published on 01/14/2025 at 07:05, 1 year 5 months ago

Biophytis en Négociation Exclusive pour Licencier BIO101 en Chine

Biophytis Négociation Exclusive Chine Pharmaceutique BIO101
REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year 5 months ago

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101
Biophytis enters exclusive negotiations with a Chinese pharmaceutical company to license BIO101 for viral respiratory infections, sarcopenia, and obesity. The potential partnership aims to develop and commercialize the drug in China's growing pharmaceutical market

Biophytis Exclusive Negotiations Chinese Pharmaceutical Company BIO101 License Viral Respiratory Infections
REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year 5 months ago

Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101
Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101. L'objectif est de co-développer et commercialiser le traitement en Chine

Biophytis Négociation Exclusive BIO101 Co-développement Société Pharmaceutique Chinoise
BRIEF

published on 01/08/2025 at 07:05, 1 year 5 months ago

Biophytis obtient des financements pour son programme d'obésité

Investissement Biophytis Refinancement BIO101 Obésité
BRIEF

published on 01/08/2025 at 07:05, 1 year 5 months ago

Biophytis Secures €8.6 Million for Obesity Program

Clinical Development Debt Conversion Obesity Program Biophytis Financing New Investors
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 5 months ago

Biophytis annonce un nouvel apport en cash et une conversion de dettes pouvant atteindre 8,6 M€ pour financer son programme dans l’obésité
Biophytis annonce un nouvel apport en cash de 2,5 M€ et une conversion de dettes jusqu'à 6,1 M€ pour financer son programme dans l'obésité. Opération de refinancement de 8,6 M€ pour consolider sa structure financière et lancer l'étude de phase 2 OBA aux États-Unis

Biophytis Financement Développement Clinique Opération Financière Obésité
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 5 months ago

Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program
Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development

Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution

Accesswire

Published on 06/23/2026 at 19:15, 2 hours 27 minutes ago

Fox River Obtains Securityholder Approval for Plan of Arrangement with Avenir Minerals Limited
Published on 06/23/2026 at 16:10, 5 hours 32 minutes ago

Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity
Published on 06/23/2026 at 16:00, 5 hours 42 minutes ago

Secure Blockchain Appoints Former Polygon Executive Steven Bryson-Haynes as CEO to Drive Enterprise AI Commercialization
Published on 06/23/2026 at 15:45, 5 hours 57 minutes ago

Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
Published on 06/23/2026 at 15:30, 6 hours 12 minutes ago

Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board

View all ACCESSWIRE

EQS Group

Published on 06/23/2026 at 20:15, 1 hour 27 minutes ago

EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:59, 2 hours 43 minutes ago

Holding(s) in Company
Published on 06/23/2026 at 18:30, 3 hours 12 minutes ago

IEVA GROUP: COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ANNUELLE DU 23 JUIN 2026
Published on 06/23/2026 at 17:55, 3 hours 47 minutes ago

ABO Energy ABO Energy drives strategic development and future financing solution forward
Published on 06/23/2026 at 17:53, 3 hours 49 minutes ago

LIGHTON: LightOn confirms the total amount of its bond financing

Les Echos

Published on 06/23/2026 at 19:47, 1 hour 54 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 1 hour 54 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 2 hours 32 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 2 hours 32 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 3 hours 10 minutes ago

Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix

View all LES ECHOS COMFI WIRE